147 related articles for article (PubMed ID: 38280460)
1. 3D-Suspension culture platform for high throughput screening of neurotoxic chemicals using LUHMES dopaminergic neurons.
Tong ZB; Huang R; Braisted J; Chu PH; Simeonov A; Gerhold DL
SLAS Discov; 2024 Apr; 29(3):100143. PubMed ID: 38280460
[TBL] [Abstract][Full Text] [Related]
2. Characterization of three human cell line models for high-throughput neuronal cytotoxicity screening.
Tong ZB; Hogberg H; Kuo D; Sakamuru S; Xia M; Smirnova L; Hartung T; Gerhold D
J Appl Toxicol; 2017 Feb; 37(2):167-180. PubMed ID: 27143523
[TBL] [Abstract][Full Text] [Related]
3. The MT1G Gene in LUHMES Neurons Is a Sensitive Biomarker of Neurotoxicity.
Tong ZB; Braisted J; Chu PH; Gerhold D
Neurotox Res; 2020 Dec; 38(4):967-978. PubMed ID: 32870474
[TBL] [Abstract][Full Text] [Related]
4. A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis.
Smirnova L; Harris G; Delp J; Valadares M; Pamies D; Hogberg HT; Waldmann T; Leist M; Hartung T
Arch Toxicol; 2016 Nov; 90(11):2725-2743. PubMed ID: 26647301
[TBL] [Abstract][Full Text] [Related]
5. SH-SY5Y and LUHMES cells display differential sensitivity to MPP+, tunicamycin, and epoxomicin in 2D and 3D cell culture.
Ko KR; Tam NW; Teixeira AG; Frampton JP
Biotechnol Prog; 2020 Mar; 36(2):e2942. PubMed ID: 31756288
[TBL] [Abstract][Full Text] [Related]
6. The Toxmatrix: Chemo-Genomic Profiling Identifies Interactions That Reveal Mechanisms of Toxicity.
Tong ZB; Huang R; Wang Y; Klumpp-Thomas CA; Braisted JC; Itkin Z; Shinn P; Xia M; Simeonov A; Gerhold DL
Chem Res Toxicol; 2018 Feb; 31(2):127-136. PubMed ID: 29156121
[TBL] [Abstract][Full Text] [Related]
7. 3D Differentiation of LUHMES Cell Line to Study Recovery and Delayed Neurotoxic Effects.
Harris G; Hogberg H; Hartung T; Smirnova L
Curr Protoc Toxicol; 2017 Aug; 73():11.23.1-11.23.28. PubMed ID: 28777440
[TBL] [Abstract][Full Text] [Related]
8. High-content imaging of 3D-cultured neural stem cells on a 384-pillar plate for the assessment of cytotoxicity.
Joshi P; Kang SY; Yu KN; Kothapalli C; Lee MY
Toxicol In Vitro; 2020 Jun; 65():104765. PubMed ID: 31923580
[TBL] [Abstract][Full Text] [Related]
9. Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.
Zhang XM; Yin M; Zhang MH
Acta Pharmacol Sin; 2014 Jul; 35(7):945-56. PubMed ID: 24989254
[TBL] [Abstract][Full Text] [Related]
10. High yield derivation of enriched glutamatergic neurons from suspension-cultured mouse ESCs for neurotoxicology research.
Hubbard KS; Gut IM; Lyman ME; Tuznik KM; Mesngon MT; McNutt PM
BMC Neurosci; 2012 Oct; 13():127. PubMed ID: 23095170
[TBL] [Abstract][Full Text] [Related]
11. A Parkinson's Disease-relevant Mitochondrial and Neuronal Morphology High-throughput Screening Assay in LUHMES Cells.
Leah T; Vazquez-Villaseñor I; Ferraiuolo L; Wharton SB; Mortiboys H
Bio Protoc; 2021 Jan; 11(1):e3881. PubMed ID: 33732769
[TBL] [Abstract][Full Text] [Related]
12. Performance evaluation of 3D polystyrene 96-well plates with human neural stem cells in a calcium assay.
Lai Y; Kisaalita WS
J Lab Autom; 2012 Aug; 17(4):284-92. PubMed ID: 22496208
[TBL] [Abstract][Full Text] [Related]
13. High-Throughput Screening of Compound Neurotoxicity Using 3D-Cultured Neural Stem Cells on a 384-Pillar Plate.
Kang SY; Joshi P; Lee MY
Curr Protoc; 2021 Apr; 1(4):e107. PubMed ID: 33887124
[TBL] [Abstract][Full Text] [Related]
14. Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson's disease.
Harischandra DS; Rokad D; Ghaisas S; Verma S; Robertson A; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165533. PubMed ID: 31442530
[TBL] [Abstract][Full Text] [Related]
15. Neuronal Differentiation of LUHMES Cells Induces Substantial Changes of the Proteome.
Tüshaus J; Kataka ES; Zaucha J; Frishman D; Müller SA; Lichtenthaler SF
Proteomics; 2021 Jan; 21(1):e2000174. PubMed ID: 32951307
[TBL] [Abstract][Full Text] [Related]
16. 3-Dimensional culture systems for anti-cancer compound profiling and high-throughput screening reveal increases in EGFR inhibitor-mediated cytotoxicity compared to monolayer culture systems.
Howes AL; Richardson RD; Finlay D; Vuori K
PLoS One; 2014; 9(9):e108283. PubMed ID: 25247711
[TBL] [Abstract][Full Text] [Related]
17. A high-throughput approach to identify specific neurotoxicants/ developmental toxicants in human neuronal cell function assays.
Delp J; Gutbier S; Klima S; Hoelting L; Pinto-Gil K; Hsieh JH; Aichem M; Klein K; Schreiber F; Tice RR; Pastor M; Behl M; Leist M
ALTEX; 2018; 35(2):235-253. PubMed ID: 29423527
[TBL] [Abstract][Full Text] [Related]
18. Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery.
Leite PEC; Pereira MR; Harris G; Pamies D; Dos Santos LMG; Granjeiro JM; Hogberg HT; Hartung T; Smirnova L
Part Fibre Toxicol; 2019 Jun; 16(1):22. PubMed ID: 31159811
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress-induced posttranslational modifications of alpha-synuclein: specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity.
Xiang W; Schlachetzki JC; Helling S; Bussmann JC; Berlinghof M; Schäffer TE; Marcus K; Winkler J; Klucken J; Becker CM
Mol Cell Neurosci; 2013 May; 54():71-83. PubMed ID: 23369945
[TBL] [Abstract][Full Text] [Related]
20. Development of a miniaturized 3D organoid culture platform for ultra-high-throughput screening.
Du Y; Li X; Niu Q; Mo X; Qui M; Ma T; Kuo CJ; Fu H
J Mol Cell Biol; 2020 Aug; 12(8):630-643. PubMed ID: 32678871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
